glp-1 bacteria GLP-1s & Your Gut Microbiome GLP-1 Science Page

compounded GLP-1s are created by licensed compounding pharmacies using the same active ingredients

(EASD) International Diabetes Federation EQUIP Ltd Analysis from the SELECT trial, published in The Lancet, reveals that semaglutide significantly reduces cardiovascular risk in patients with obesity and established heart disease, independent of how much weight they lose

They are a tool

A key finding: while 81% of human resource (HR) decision-makers feel that their employees would be interested, only 25% cover GLP-1s today

Where Direct Primary Care Makes a Difference One of the challenges many people face is trying to discuss weight, nutrition, diabetes prevention or metabolic health during a rushed office visit